REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmasander S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmacies and Drug Stores
Full name: Pharmasander S.A.S. Profile Updated: April 08, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Pharmasander S.A.S. is a company in Colombia, with a head office in Piedecuesta. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Pharmasander S.A.S. was incorporated on January 26, 2022. The total number of employees is currently 22 (2026). The latest financial highlights indicate a net sales revenue increase of 29.64% in 2025. During that time, Pharmasander S.A.S.’s total assets grew by 48.52%. The net profit margin of Pharmasander S.A.S. decreased by 3.76% in 2025.

Headquarters
Carrera 14 # 9 - 50 Barrio San Antonio
Piedecuesta; Santander;

Contact Details: Purchase the Pharmasander S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmasander S.A.S. report to view the information.
Financial Auditors:
Purchase the Pharmasander S.A.S. report to view the information.
Incorporation Date:
January 26, 2022
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Pharmasander S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
29.64%
Total Operating Revenue
29.64%
Net Profit/Loss for the Period
-31.57%
Total Assets
48.52%
Total Equity
48.29%
Net Profit Margin
-3.76%
Return on Equity (ROE)
-38%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?